Dagoberto Cortés Cervantes – Director, Grupo Sanfer/Hormona Mexico

Dagoberto Cortes Dagoberto Cortés Cervantes, president of Mexico's National Association of Medicines Manufacturers (ANAFAM) and director of Grupo Sanfer/Hormona Mexico, outlines the expansion strategy that has led the manufacturing group to extend its presence beyond Mexico into the broader LatAm region and the importance of the "Alianza del Pacifico"  trade agreement linking the country to Chile, Colombia, and Peru. Moreover, he discusses the segmentation of Mexico's public and private markets, its pharmaceutical sovereignty, and the company's vast product portfolio.
In Mexico 85 percent of the medicines consumed by the population are produced in the country itself. For this reason, Mexico is considered one of the few countries in the world that enjoys pharmaceutical sovereignty.  We can be proud that although in recent tenders the doors were opened to international pharmaceutical companies, 87 percent of government procurement went to Mexican manufacturers.
Become a PharmaBoardroom Member for free to access this content
Join the 35,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report